Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Liozon

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Medicine|October 21, 2016
Steroid-sparing effect and toxicity of dapsone treatment in giant cell arteritis: A single-center, retrospective study of 70 patientsKim Heang Ly, François Dalmay, Guillaume Gondran, et al.
Seminars in Arthritis and Rheumatism|October 16, 2020
Risk profiling for a refractory course of giant cell arteritis: The importance of age and body weight: "Risk profiling for GC resistance in GCA"Eric Liozon, Stéphanie Dumonteil, Simon Parreau, et al.
Autoimmunity Reviews|December 16, 2020
Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature reviewEric Liozon, Simon Parreau, Matthieu Filloux, et al.
Joint Bone Spine|July 6, 2010
Behçet's disease in East African patients may not be unusual and is an HLA-B51 negative condition: a case series from Mayotte (Comoros)Eric Liozon, Céline Roussin, Xavier Puéchal, et al.
The Journal of Rheumatology|July 13, 2006
Concurrent temporal (giant cell) arteritis and malignancy: report of 20 patients with review of the literatureEric Liozon, Véronique Loustaud, Anne-Laure Fauchais, et al.
Plos One|July 30, 2013
Recovery of adrenal function after long-term glucocorticoid therapy for giant cell arteritis: a cohort studyYvan Jamilloux, Eric Liozon, Gregory Pugnet, et al.
Clinical and Experimental Rheumatology|May 6, 2022
Features and risk factors for new (secondary) permanent visual involvement in giant cell arteritisMuhammad Faiz Curumthaullee, Eric Liozon, Stéphanie Dumonteil, et al.
Seminars in Arthritis and Rheumatism|May 5, 2022
Giant cell arteritis-related stroke in a large inception cohort: A comparative studySimon Parreau, Stéphanie Dumonteil, Francisco Macian Montoro, et al.
Medicine|July 2, 2016
Giant-cell arteritis without cranial manifestations: Working diagnosis of a distinct disease patternHubert de Boysson, Marc Lambert, Eric Liozon, et al.
Survey of Ophthalmology|August 22, 2022
Temporal artery biopsy: A technical guide and review of its importance and indicationsSimon Parreau, Eric Liozon, John J Chen, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Medicine|October 21, 2016
Steroid-sparing effect and toxicity of dapsone treatment in giant cell arteritis: A single-center, retrospective study of 70 patientsKim Heang Ly, François Dalmay, Guillaume Gondran, et al.
Seminars in Arthritis and Rheumatism|October 16, 2020
Risk profiling for a refractory course of giant cell arteritis: The importance of age and body weight: "Risk profiling for GC resistance in GCA"Eric Liozon, Stéphanie Dumonteil, Simon Parreau, et al.
Autoimmunity Reviews|December 16, 2020
Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature reviewEric Liozon, Simon Parreau, Matthieu Filloux, et al.
Joint Bone Spine|July 6, 2010
Behçet's disease in East African patients may not be unusual and is an HLA-B51 negative condition: a case series from Mayotte (Comoros)Eric Liozon, Céline Roussin, Xavier Puéchal, et al.
The Journal of Rheumatology|July 13, 2006
Concurrent temporal (giant cell) arteritis and malignancy: report of 20 patients with review of the literatureEric Liozon, Véronique Loustaud, Anne-Laure Fauchais, et al.
Plos One|July 30, 2013
Recovery of adrenal function after long-term glucocorticoid therapy for giant cell arteritis: a cohort studyYvan Jamilloux, Eric Liozon, Gregory Pugnet, et al.
Clinical and Experimental Rheumatology|May 6, 2022
Features and risk factors for new (secondary) permanent visual involvement in giant cell arteritisMuhammad Faiz Curumthaullee, Eric Liozon, Stéphanie Dumonteil, et al.
Seminars in Arthritis and Rheumatism|May 5, 2022
Giant cell arteritis-related stroke in a large inception cohort: A comparative studySimon Parreau, Stéphanie Dumonteil, Francisco Macian Montoro, et al.
Medicine|July 2, 2016
Giant-cell arteritis without cranial manifestations: Working diagnosis of a distinct disease patternHubert de Boysson, Marc Lambert, Eric Liozon, et al.
Survey of Ophthalmology|August 22, 2022
Temporal artery biopsy: A technical guide and review of its importance and indicationsSimon Parreau, Eric Liozon, John J Chen, et al.
Pageof 9